Heinrich-Heine-Universität Düsseldorf

Düsseldorf, North Rhine-Westphalia 40225

0 studies enrolling now · 4 studies all time

What they study most

Acute Non-cardioembolic Ischemic Stroke, Carcinoma, Transitional Cell, Heart Failure, Hepatocellular Carcinoma

Studies at this site

• Regorafenib Plus Pembrolizumab in Patients With Advanced or Spreading Liver Cancer Who Have Been Previously Treated With PD-1/PD-L1 Immune Checkpoint Inhibitors — Completed
• REALIsM-HF Pilot Study — Completed
• Study to Gather Information About Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following a Recent Non Cardioembolic Ischemic Stroke Which Occurs When a Blood Clot Has Formed Somewhere in the Human Body (But Not in the Heart) Travelled to the Brain. — Completed
• Study of Rogaratinib (BAY1163877) vs Chemotherapy in Patients With FGFR (Fibroblast Growth Factor Receptor)-Positive Locally Advanced or Metastatic Urothelial Carcinoma — Completed